🌐 EnglishEN

AI Cure is a research tool showing open data. Not medical advice. Discuss with your doctor. Terms

🧪

Trial Match

Clinical trials test new treatments — sometimes the newest options available for a disease. Find trials that are recruiting now, near you. Open one to see its eligibility rules as simple questions to go through with your doctor.

Know your stage or your test results (such as EGFR, HER2 or BRCA)? Match trials to your own profile - nothing you type is saved.

🎯 Match trials to me

30 recruiting trials

for Varicella-zoster Virus

A Study on the Immune Response and Safety of an Investigational Combined Measles, Mumps, Rubella and Varicella Vaccine, When Administered as Intramuscular Injection to Healthy Children 15 Months to 6 Years of Age NCT07406360Phase 317 sites📍 Birmingham📍 Walnut Creek📍 Miami GlaxoSmithKline · Tests: MMRVNS, MMRV Safety and Immunogenicity of Recombinant Varicella Zoster Virus Vaccine in People With HIV Who Have a CD4 Count Less Than 300 or Greater Than or Equal to 300 and a Healthy Control Population NCT05580458Phase 1, Phase 21 site📍 Bethesda National Institute of Allergy and Infectious Diseases (NIAI… · Tests: Shingrix Is a Third Dose of MMRV Vaccine Beneficial for the Adult Population in Alberta? NCT05923970n/a1 site📍 Edmonton University of Alberta · Tests: Serology for antibody levels - Baseline, Serology to assess cell mediated immune (CMI) response - Baseline, Serology fo… The Analgesic Efficacy and Safety of Desvenlafaxine in Patients With Herpes Zoster NCT07361809NA1 site📍 Beijing Beijing Tiantan Hospital · Tests: Desvenlafaxine combined conventional therapy, Conventional therapy A Study to Test GlaxoSmithKline's (GSK) Candidate Vaccine-GSK1437173A for Prevention of Shingles in Children With Kidney Transplant NCT04006808Phase 1, Phase 231 sites📍 Brussels📍 Ghent📍 Leuven GlaxoSmithKline · Tests: PED-HZ/su Evaluate the Safety and Immunogenicity After MG1111(BARICELA Inj.) as 2nd Vaccination in 4 ~ 6 Year Old Healthy Children With a History of 1st Varicella Vaccination NCT05422508Phase 21 site📍 Ansan Green Cross Corporation · Tests: MG1111 (BARICELA), VARIVAX, Suduvax Study to Evaluate the Safety and Immunogenicity of a Lyophilized Herpes Zoster Virus mRNA Vaccine NCT07400003Phase 1, Phase 21 site📍 Xinjiang Sinovac Biotech Co., Ltd · Tests: Low-dose experimental vaccine, High-dose experimental vaccine, Active-controlled vaccine A, Active-controlled vaccine B… Immunogenicity, Efficacy and Safety of Recombinant Herpes Zoster Vaccine in Frail Patients NCT07321808n/a1 site📍 Pavia Fondazione IRCCS Policlinico San Matteo di Pavia Electroacupuncture Regulation of Immune Cells in Herpes Zoster NCT06643247NA1 site📍 Hangzhou First People's Hospital of Hangzhou · Tests: Drug, Electroacupuncture Risk Factors of Anxiety and Depression in Patients With Herpes Zoster Neuralgia NCT06449547n/a1 site📍 Wuhan Huazhong University of Science and Technology · Tests: Hospital Anxiety and Depression Scale Long-term Effectiveness of the Live Attenuated Herpes Zoster Vaccine NCT07585370n/a1 site📍 Nanjing Jiangsu Province Centers for Disease Control and Prevention · Tests: Attenuated Zoster Vaccine, Live, Matched Placebo Without Live Virus, Attenuated Zoster Vaccine, Live Second Dose of Varicella Vaccine in Healthy Children NCT07475000Phase 35 sites📍 Akdeniz📍 Ankara📍 Ankara Sinovac (Dalian) Vaccine Technology Co., Ltd. · Tests: PROVARIX The Analgesic Efficacy and Safety of Baclofen in Patients With Herpes Zoster NCT07378046NA1 site📍 Beijing Beijing Tiantan Hospital · Tests: Baclofen combined conventional therapy, Conventional therapy Phase III Clinical Trial of Lyophilized Herpes Zoster mRNA Vaccine in Adults Aged 40 Years or Above NCT07817108Phase 34 sites📍 Jinan📍 Nanning📍 Shijiazhuang Suzhou Abogen Biosciences Co., Ltd. · Tests: ABO1108, Placebo Pediatric and Ambulatory Research in Infectious Diseases NCT04471493n/a1 site📍 Créteil Association Clinique Thérapeutique Infantile du val de Marne A Phase Ⅲ Clinical Study to Evaluate Protective Efficacy and Safety of a Recombinant Herpes Zoster Vaccine NCT06088745Phase 31 site📍 Zhenjiang Beijing Luzhu Biotechnology Co., Ltd. · Tests: Recombinant Herpes Zoster Vaccine, Recombinant Herpes Zoster Vaccine Placebo The Analgesic Efficacy and Safety of Crisugabalin in Patients With Herpes Zoster NCT07307976NA1 site📍 Beijing Beijing Tiantan Hospital · Tests: Crisugabalin combined conventional therapy, Conventional therapy Shingrix in Renal Transplant Recipients NCT04128189Phase 34 sites📍 Aurora📍 Atlanta📍 Boston University of Colorado, Denver · Tests: Shingrix The Analgesic Efficacy and Safety of Mirogabalin in Patients With Herpes Zoster NCT07307170NA1 site📍 Beijing Beijing Tiantan Hospital · Tests: Mirogabalin combined conventional therapy, Conventional therapy A Study on the Immune Response and Safety of the Second Dose of an Investigational Chickenpox Vaccine When Given to Healthy Children 3 Months After a First Dose at 12 to 15 Months of Age NCT06806137Phase 36 sites📍 Salvaleón de Higüey📍 Constanza📍 Santo Domingo Oeste GlaxoSmithKline · Tests: Investigational varicella vaccine, Marketed varicella vaccine, MMR vaccine, Hepatitis A vaccine, PCV (pneumococcal conj… Reduced Vaccine Response to HZ/su in SLE NCT07636044n/a1 site📍 Seoul Seoul National University Hospital The Analgesic Efficacy and Safety of Flurbiprofen Patch in Patients With Herpes Zoster NCT07370402NA1 site📍 Beijing Beijing Tiantan Hospital · Tests: Flurbiprofen patch combined with conventional therapy group, Conventional therapy group Erector Spinae Plane Block Versus Transcutaneous Radiofrequency in Postherpetic Neuralgia NCT07400640n/a1 site📍 Ankara Diskapi Teaching and Research Hospital · Tests: Erector Spinae Plane Block Efficacy and Safety of Brivudine in the Treatment of Herpes Zoster NCT07099157Phase 44 sites📍 Beijing📍 Beijing📍 Beijing Peking University Third Hospital · Tests: Brivudine, Famciclovir Esketamine Combined Pulsed Radiofrequency for Acute/Subacute Zoster-associated Trigeminal Neuralgia NCT06890897NA1 site📍 Beijing Beijing Tiantan Hospital · Tests: Esketamine group, PRF group A Study on the Immune Response and Safety of an Investigational Chickenpox Vaccine When Given to Healthy Children 12 to 15 Months of Age NCT06740630Phase 397 sites📍 Mobile📍 Hot Springs📍 Sherwood GlaxoSmithKline · Tests: Investigational varicella vaccine_Lot 1, Investigational varicella vaccine_Lot 2, Investigational varicella vaccine_Lot… Immunogenicity of Zoster Vaccine in Allogeneic Hematopoietic Stem Cell Transplant Recipients NCT05554068Phase 21 site📍 Maywood Loyola University · Tests: Shingrix A Study to Evaluate the Effect of Recombinant Zoster Vaccine on New Diagnosis of Dementia in an Older Adult Population Aged 76 Years or Older in Finland NCT07502560Phase 48 sites📍 Espoo📍 Helsinki📍 Jarvenpaa GlaxoSmithKline · Tests: Recombinant zoster vaccine, Placebo Safety and Immunogenicity of the Recombinant Zoster Vaccine, LYB004 in Adults Aged 40 Years and Older NCT06874842Phase 11 site📍 Meizhou Guangzhou Patronus Biotech Co., Ltd. · Tests: Low dose antigen and low dose adjuvant of LYB004, Low dose antigen and high dose adjuvant of LYB004, High dose antigen … Risk Assessment of Community Spread of Multiple Endemic Infectious Diseases in a One Health Perspective NCT07358910n/a1 site📍 Phnom Penh Institut Pasteur du Cambodge
🛡️

AI Cure shows public evidence (Open Targets, ClinicalTrials.gov, PubMed, openFDA, DepMap, AlphaFold) with its source, and AI summaries that cite it — not medical advice and not a cure. Treatment decisions belong with your doctor. Research ideas are shared only with approved researchers and labs, who can test them. In an emergency call your local emergency number (112 in India and Europe, 911 in the US). AI Cure Terms of Use · Privacy